BERKELEY'S NEWS • NOVEMBER 18, 2023
Andy Murdock
Page 1 of 1
Research & Ideas
DECEMBER 02, 2022
UC Berkeley, UCSF scientists find diverse CRISPR gene editors in viruses
Researchers at UC Berkeley and UCSF’s Innovative Genomics Institute, or IGI, have found the diversity of CRISPR gene editors in viruses goes far beyond what they expected, possibly leading to new ways of editing genomes.
Research & Ideas
DECEMBER 02, 2022
UC Berkeley, UCSF scientists find diverse CRISPR gene editors in viruses
Researchers at UC Berkeley and UCSF’s Innovative Genomics Institute, or IGI, have found the diversity of CRISPR gene editors in viruses goes far beyond what they expected, possibly leading to new ways of editing genomes.
Research & Ideas
APRIL 01, 2021
FDA approves CRISPR gene therapy trials for sickle cell disease
CRISPR genome editing technology, which was developed at UC Berkeley, has been approved for clinical trials to correct gene mutations responsible for sickle cell disease.
Research & Ideas
APRIL 01, 2021
FDA approves CRISPR gene therapy trials for sickle cell disease
CRISPR genome editing technology, which was developed at UC Berkeley, has been approved for clinical trials to correct gene mutations responsible for sickle cell disease.
Research & Ideas
FEBRUARY 07, 2021
Campus researchers sequence coronavirus genome, find several strains
Amid a surge in COVID-19 cases and the detection of new variants of the virus on campus, the Innovative Genomics Institute, or IGI, at UC Berkeley aims to sequence viral genomes to improve student safety.
Research & Ideas
FEBRUARY 07, 2021
Campus researchers sequence coronavirus genome, find several strains
Amid a surge in COVID-19 cases and the detection of new variants of the virus on campus, the Innovative Genomics Institute, or IGI, at UC Berkeley aims to sequence viral genomes to improve student safety.
Research & Ideas
OCTOBER 27, 2020
UC Berkeley institute to end COVID-19 saliva test trial
UC Berkeley's Innovative Genomics Institute, or IGI's, Free Asymptomatic Saliva Test, or FAST, study for COVID-19 will end Thursday after having tested more than 4,800 people, according Jennifer Doudna, president and chair of the IGI governance board
Research & Ideas
OCTOBER 27, 2020
UC Berkeley institute to end COVID-19 saliva test trial
UC Berkeley's Innovative Genomics Institute, or IGI's, Free Asymptomatic Saliva Test, or FAST, study for COVID-19 will end Thursday after having tested more than 4,800 people, according Jennifer Doudna, president and chair of the IGI governance board
Research & Ideas
OCTOBER 09, 2020
UC Berkeley professor Jennifer Doudna receives Nobel Prize in chemistry
Jennifer Doudna, UC Berkeley professor of chemistry, biochemistry and molecular biology, was awarded half of the Nobel Prize in chemistry Wednesday for developing the gene-editing technology CRISPR-Cas9.
Research & Ideas
OCTOBER 09, 2020
UC Berkeley professor Jennifer Doudna receives Nobel Prize in chemistry
Jennifer Doudna, UC Berkeley professor of chemistry, biochemistry and molecular biology, was awarded half of the Nobel Prize in chemistry Wednesday for developing the gene-editing technology CRISPR-Cas9.
